MedTech — Cost of products sold
Business Segments · Cost of products soldJohnson & Johnson MedTech — Cost of products sold decreased by 0.7% to $3.61B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $3.38B to $3.61B. Over 2 years (FY 2022 to FY 2024), MedTech — Cost of products sold shows an upward trend with a 13.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ3 2025
Rolls up toTotal Cost of Revenue
How to read this metric
Lower costs relative to revenue indicate improved manufacturing efficiency and higher profitability.
Detailed definition
Includes the direct costs associated with manufacturing, sourcing, and distributing medical devices sold by the segment....
Peer comparison
Standard cost of goods sold (COGS) metric for manufacturing segments.
Metric ID:
jnj_segment_medtech_cost_of_products_soldHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60B | $2.60B | $2.60B | $2.60B | $3.18B | $3.18B | $3.18B | $3.18B | $3.12B | $3.25B | $3.38B | $3.60B | $3.33B | $3.64B | $3.61B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +22.4% | +0.0% | +0.0% | +0.0% | -1.9% | +4.1% | +4.1% | +6.4% | -7.5% | +9.4% | -0.7% |
| YoY Change | — | — | — | — | +22.4% | +22.4% | +22.4% | +22.4% | -1.9% | +2.1% | +6.3% | +13.1% | +6.6% | +12.0% | +6.8% |
Range$2.60B – $3.64B
CAGR+9.9%
Avg YoY Growth+12.2%
Median YoY Growth+12.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — cost of products sold?
- Johnson & Johnson (JNJ) reported medtech — cost of products sold of $3.61B in Q3 2025.
- How has Johnson & Johnson's medtech — cost of products sold changed year-over-year?
- Johnson & Johnson's medtech — cost of products sold increased by 6.8% year-over-year, from $3.38B to $3.61B.
- What is the long-term trend for Johnson & Johnson's medtech — cost of products sold?
- Over 2 years (2022 to 2024), Johnson & Johnson's medtech — cost of products sold has grown at a 13.3% compound annual growth rate (CAGR), from $10.40B to $13.35B.
- What does medtech — cost of products sold mean?
- The direct costs incurred to produce and deliver the medical devices sold.